Literature DB >> 23569889

Strategies for production of active eukaryotic proteins in bacterial expression system.

Orawan Khow1, Sunutcha Suntrarachun.   

Abstract

Bacteria have long been the favorite expression system for recombinant protein production. However, the flaw of the system is that insoluble and inactive proteins are co-produced due to codon bias, protein folding, phosphorylation, glycosylation, mRNA stability and promoter strength. Factors are cited and the methods to convert to soluble and active proteins are described, for example a tight control of Escherichia coli milieu, refolding from inclusion body and through fusion technology.

Entities:  

Keywords:  Escherichia coli; Expression; Recombinant protein

Mesh:

Substances:

Year:  2012        PMID: 23569889      PMCID: PMC3609253          DOI: 10.1016/S2221-1691(11)60213-X

Source DB:  PubMed          Journal:  Asian Pac J Trop Biomed        ISSN: 2221-1691


  27 in total

Review 1.  Strategies to maximize heterologous protein expression in Escherichia coli with minimal cost.

Authors:  Wolfgang Peti; Rebecca Page
Journal:  Protein Expr Purif       Date:  2006-07-04       Impact factor: 1.650

Review 2.  Select what you need: a comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes.

Authors:  Jiechao Yin; Guangxing Li; Xiaofeng Ren; Georg Herrler
Journal:  J Biotechnol       Date:  2006-07-26       Impact factor: 3.307

3.  A strategy for high-level expression of soluble and functional human interferon alpha as a GST-fusion protein in E. coli.

Authors:  Imen Rabhi-Essafi; Amine Sadok; Noureddine Khalaf; Dahmani M Fathallah
Journal:  Protein Eng Des Sel       Date:  2007-04-12       Impact factor: 1.650

Review 4.  Strategies for efficient production of heterologous proteins in Escherichia coli.

Authors:  S Jana; J K Deb
Journal:  Appl Microbiol Biotechnol       Date:  2005-01-06       Impact factor: 4.813

Review 5.  Solubilization and refolding of bacterial inclusion body proteins.

Authors:  Surinder Mohan Singh; Amulya Kumar Panda
Journal:  J Biosci Bioeng       Date:  2005-04       Impact factor: 2.894

Review 6.  Expression of highly toxic genes in E. coli: special strategies and genetic tools.

Authors:  F Saïda; M Uzan; B Odaert; F Bontems
Journal:  Curr Protein Pept Sci       Date:  2006-02       Impact factor: 3.272

Review 7.  Strain engineering for improved expression of recombinant proteins in bacteria.

Authors:  Tomohiro Makino; Georgios Skretas; George Georgiou
Journal:  Microb Cell Fact       Date:  2011-05-14       Impact factor: 5.328

8.  A family of E. coli expression vectors for laboratory scale and high throughput soluble protein production.

Authors:  Lisa D Cabrita; Weiwen Dai; Stephen P Bottomley
Journal:  BMC Biotechnol       Date:  2006-03-01       Impact factor: 2.563

9.  Viral promoters can initiate expression of toxin genes introduced into Escherichia coli.

Authors:  Astrid Lewin; Martin Mayer; Janet Chusainow; Daniela Jacob; Bernd Appel
Journal:  BMC Biotechnol       Date:  2005-06-20       Impact factor: 2.563

10.  Chaperone-based procedure to increase yields of soluble recombinant proteins produced in E. coli.

Authors:  Ario de Marco; Elke Deuerling; Axel Mogk; Toshifumi Tomoyasu; Bernd Bukau
Journal:  BMC Biotechnol       Date:  2007-06-12       Impact factor: 2.563

View more
  41 in total

Review 1.  Metabolic glycoengineering bacteria for therapeutic, recombinant protein, and metabolite production applications.

Authors:  Christopher T Saeui; Esteban Urias; Lingshu Liu; Mohit P Mathew; Kevin J Yarema
Journal:  Glycoconj J       Date:  2015-05-01       Impact factor: 2.916

2.  High-level production of Fc-fused kringle domain in Pichia pastoris.

Authors:  Gu Min Jeong; Yong Jae Lee; Yong Sung Kim; Ki Jun Jeong
Journal:  J Ind Microbiol Biotechnol       Date:  2014-03-30       Impact factor: 3.346

3.  Expression and one step intein-mediated purification of biologically active human G-CSF in Escherichia coli.

Authors:  Setareh Sima; Fatemeh Shafiee; Ali Jahanian-Najafabadi
Journal:  Mol Biol Rep       Date:  2020-03-29       Impact factor: 2.316

4.  Neuraminidase 1-mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against Pseudomonas aeruginosa lung infection.

Authors:  Erik P Lillehoj; Wei Guang; Sang W Hyun; Anguo Liu; Nicolas Hegerle; Raphael Simon; Alan S Cross; Hideharu Ishida; Irina G Luzina; Sergei P Atamas; Simeon E Goldblum
Journal:  J Biol Chem       Date:  2018-11-14       Impact factor: 5.157

5.  HIV-1 Resistance to Dolutegravir Is Affected by Cellular Histone Acetyltransferase Activity.

Authors:  Kaitlin Anstett; Bluma Brenner; Thibault Mesplède; Mark A Wainberg
Journal:  J Virol       Date:  2017-10-13       Impact factor: 5.103

6.  Cloning, Expression, and Characterization of Siamese Crocodile (Crocodylus siamensis) Hemoglobin from Escherichia coli and Pichia pastoris.

Authors:  Preeyanan Anwised; Nisachon Jangpromma; Theeranan Temsiripong; Rina Patramanon; Sakda Daduang; Sarawut Jitrapakdee; Tomohiro Araki; Sompong Klaynongsruang
Journal:  Protein J       Date:  2016-08       Impact factor: 2.371

7.  Biochemical characterization of the mouse ABCF3 protein, a partner of the flavivirus-resistance protein OAS1B.

Authors:  Elizabeth Peterson; Emma Shippee; Margo A Brinton; Parjit Kaur
Journal:  J Biol Chem       Date:  2019-08-14       Impact factor: 5.157

8.  Soluble expression, purification, and secondary structure determination of human MESP1 transcription factor.

Authors:  Krishna Kumar Haridhasapavalan; Sujal Harsh Ranjan; Srirupa Bhattacharyya; Rajkumar P Thummer
Journal:  Appl Microbiol Biotechnol       Date:  2021-03-02       Impact factor: 4.813

Review 9.  The omic approach to parasitic trematode research-a review of techniques and developments within the past 5 years.

Authors:  Orçun Haçarız; Gearóid P Sayers
Journal:  Parasitol Res       Date:  2016-04-28       Impact factor: 2.289

10.  A scalable insect cell-based production process of the human recombinant BMX for in-vitro covalent ligand high-throughput screening.

Authors:  Bárbara B Sousa; Marcos F Q Sousa; Marta C Marques; João D Seixas; José A Brito; Pedro M Matias; Gonçalo J L Bernardes; António Roldão
Journal:  Bioprocess Biosyst Eng       Date:  2020-08-20       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.